EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
0 hedge funds and large institutions have $0 invested in EnteroMedics Inc. in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $3.33M → $0 (-$3.33M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$3.33M |
ETRM Hedge Fund Activity: Q1 2018 in Review
0 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q1 2018, worth a combined $0 — down 100% from $3.33M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ETRM and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was SV Health Investors, exiting entirely with an estimated $3.33M sold.
- 0 institutional investors held EnteroMedics Inc. (ETRM) as of Q1 2018, down from 1 in Q4 2017.
- Funds reported $0 of EnteroMedics Inc. stock for Q1 2018, down 100% quarter-over-quarter.
- 0 funds opened new EnteroMedics Inc. positions in Q1 2018 and 1 closed out, a net change of -1 holder.
- The largest EnteroMedics Inc. seller in Q1 2018 was SV Health Investors, an estimated $3.33M sold.
Based on aggregated 13F filings for Q1 2018.